ADENT JOHN EDWARD

NEOG CEO John Edward Adent bought 23.0K shares at $11.03; stock -36.2% from 52-week high amid $-456.3M annual loss.

CEO John Edward Adent purchased 23,035 shares at $11.03 on 2025-01-16, increasing his holdings by 9.4% to 269.2K shares. The timing is notable given recent price weakness: the stock has declined 20.0% over 90 days and 36.2% from its 52-week high of $18.18, while trading 4.4% lower over the past 30 days. Adent's cross-ticker track record shows 2 prior buys with a 50% 90-day win rate (averaging +7.0% 90d return), but his same-ticker history at NEOG is mixed: his prior October 2024 buy was underwater 90-day (-5.3%) while his April 2024 buy recovered (+19.2%), yielding a 1-of-2 well-timed outcomes. Company fundamentals remain challenged, with the most recent full fiscal year showing a net loss of $-456.3M despite 12.4% annual revenue growth to $231.3M, indicating the company is unprofitable. The purchase occurs at depressed absolute price levels relative to the 52-week range, though whether this signals conviction or opportunistic positioning cannot be determined from the transaction alone.

NEOGEN CEO John Edward Adent buys 14,500 shares at $13.80, raising stake by 7.2% to 216,477 shares total

NEOGEN's CEO purchased 14,500 shares at $13.80 on 2024-10-11, bringing his total holdings to 216,477 shares and representing a 7.2% increase in his position. The stock has since declined 8.7% over 30 days and 16.2% over 90 days, trading at $14.73 against a 52-week high of $20.70. While the CEO's prior buy at this same ticker (2024-04-10) achieved a +19.2% return over 90 days, the company reported negative net income of $-12,609,000 in its latest quarter despite 12.4% annual revenue growth, underscoring that profitable operations remain absent. The purchase occurs in a declining market environment where the stock sits at the lower end of its recent range, and the current open-market buy follows a pattern of prior positive 90-day outcomes, though the company's persistent unprofitability creates headwinds for any conviction thesis.